NexGen Lifesciences sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by any regulatory authority.
Retatrutide is a triple agonist research peptide targeting GLP-1, GIP, and glucagon receptors. This compound is studied in laboratory settings for its potential effects on metabolic regulation, energy balance, and body composition research. Each vial contains 10MG of lyophilized Retatrutide with purity ≥ 99%, verified by third-party HPLC testing. Intended strictly for research and laboratory use only. Not for human consumption.
FDA DISCLAIMER: Statements made regarding our products have not been evaluated by any regulatory authority. These products are not intended to diagnose, treat, cure, or prevent any disease. Products are not for human or veterinary use, not for use in diagnostic procedures. For research and laboratory use only by qualified researchers.
Choosing a selection results in a full page refresh.
